Proof Of Mechanism Study To Determine Efficacy Of PF-04455242 In Blocking Spiradoline (PF-00345768) Stimulated Prolactin Release

NCT00988949 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Depression

Interventions

DRUG: PF-04455242
DRUG: spiradoline
OTHER: Placebo
DRUG: spiradoline
DRUG: PF-04455242
DRUG: spiradoline

Sponsor

Pfizer